Accelus (formerly Integrity Implants) develops and manufactures medical implants used in spinal surgery.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
12/27/2022 | Series E | $107.6MM | $xx.xx | $165.01MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
538,000,000
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.5x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
07/12/2022 | Series D | $12MM | $xx.xx | $350.02MM | Concord Health Partners | |
Price per Share
$xx.xx
Shares Outstanding
2,281,369
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Concord Health Partners
|
||||||
02/01/2020 | Series C | $14.85MM | $xx.xx | $136.35MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
3,300,000
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
03/13/2019 | Series B | $25.2MM | $xx.xx | $106.65MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
5,600,000
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
04/21/2016 | Series A | $18.75MM | $xx.xx | $46.88MM | Kinled Holdings | |
Price per Share
$xx.xx
Shares Outstanding
6,250,000
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Kinled Holdings
|